Business
LSL PHARMA GROUP ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
LSL PHARMA GROUP ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDE...
About this update from Lsl Pharma Group Inc
[{"type":"text","content":"\n\n\n\n LSL PHARMA GROUP ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n\n\n\n\n\n\n\n BOUCHERVILLE, QC\n \n\n ,\n \n\n June 27, 2025\n \n\n /CNW/ -\n \n LSL PHARMA GROUP INC\n \n . (TSXV: LSL) (\"\n \n LSL Pharma\n \n \" or the \"\n \n Corporation\n \n \"), a Canadian integrated pharmaceutical company, today announced the voting results of its annual general and special meeting of shareholders held today in\n \n Boucherville\n \n , Québec at the Corporation's headquarters (the \"\n \n Meeting\n \n \").\n \n\n\n\n Election of Directors\n \n\n\n\n Mr. François Roberge, Mr.\n \n Frank Dellafera\n \n , Mr.\n \n Mario Paradis\n \n and Mr.\n \n Louis Laflamme\n \n were elected directors of the Corporation to hold office until the next annual meeting of shareholders or until their successors are appointed or elected.\n \n\n Each of the remaining director nominees have received less than 50% of the votes cast in favour of their election. At the Corporation's request, these nominees may continue in office, for a maximum of 90 days for transition purposes, after which the Board will accept their resignations.\n \n\n Full voting results are available on SEDAR+ at\n \n www.sedarplus.ca\n \n .\n \n\n\n\n Appointment of Auditors\n \n\n\n\n Audacie Inc. has been re-appointed as auditors of the Corporation for the ensuing year and the directors are authorized to fix their remuneration.\n \n\n\n\n Approval of Stock Option Plan\n \n\n\n\n The current 10% rolling stock option plan of the Corporation has been re-approved until the next annual meeting of shareholders.\n \n\n Further disclosure on the matters approved at the Meeting, including full voting results, can be found in the notice and accompanying management information circular filed in respect of the Meeting and available on SEDAR+ at\n \n www.sedarplus.ca\n \n .\n \n\n\n ABOUT LSL PHARMA GROUP INC.\n \n\n\n LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the...